臓器保存の世界市場見通し:正常体温機械灌流、静的冷温保存(SCS)技術、低体温機械灌流

Stratistics MRCが発行した調査報告書(SMRC611047)
◆英語タイトル:Organ Preservation - Global Market Outlook (2016-2022)
◆商品コード:SMRC611047
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2016年10月
◆ページ数:154
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥468,950見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥593,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、臓器保存の世界市場について調査・分析し、臓器保存の世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・序文
・臓器保存の世界市場:市場動向分析
・臓器保存の世界市場:競争要因分析
・臓器保存の世界市場:セグメント別分析/市場規模
・臓器保存の世界市場:地域別分析/市場規模
・臓器保存の北米市場規模
・臓器保存の欧州市場規模
・臓器保存のアジア市場規模
・臓器保存の世界市場:主な市場開拓
・関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Organ Preservation market is estimated at $153.93 million in 2015 and is expected to reach $274.19 million by 2022 growing at a CAGR of 8.7% from 2015 to 2022. Organ failure cases in ageing population, Organ donation campaign by government and other organisations are the key factors driving the market growth. Huge cost associated with organ transplantation is hampering the market. Technological advancements in organ preservation seems to be opportunity for the market to grow.

By preservation solution, custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) solution accounted for the largest share because of its property to preserve various organs like liver, lung, heart and more. By technique, static cold storage (SCS) holds the largest share, whereas hypothermic machine perfusion technique is expected to move at highest CAGR due to high demand for organs and less availability. Europe is the largest market for Organ Preservation and Asia Pacific is anticipated to register significant CAGR during the forecast period.

Some of the key players in the market include Teva Pharmaceutical Industries Ltd., Dr. Franz Kohler Chemie GmbH, Xvivo Perfusion AB, Claris Lifesciences Limited, Paragonix Technologies, Inc., Transmedics, Inc., 21st Century Medicine Inc., Bridge to Life Limited, Essential Pharmaceuticals, LLC, Waters Medical Systems LLC [Institut Georges Lopez (IGL], Preservation Solutions, Inc., Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.), Organox Limited, Bristol-Myers Squibb and ToleroTech, Inc.

Organ Types Covered:
• Heart
• Kidneys
• Lung
• Liver
• Other Organs
o Pancreas
o Intestine

Techniques Covered:
• Normothermic Machine Perfusion
• Static Cold Storage (SCS) Technique
• Hypothermic Machine Perfusion

Solutions Covered:
• Perfadex
• Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution
• University of Wisconsin Solution (UW Solution)
• Human bioSystem (HBS) Solution
• Hypothermosol
• siRNA Transplant Solution
• Viaspan
• Renograf
• Lifor
• Other Preservation Solutions

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Organ Preservation Market, By Organ Type
5.1 Introduction
5.2 Heart
5.3 Kidneys
5.4 Lung
5.5 Liver
5.6 Other Organs
5.6.1 Pancreas
5.6.2 Intestine

6 Global Organ Preservation Market, By Technique
6.1 Introduction
6.2 Normothermic Machine Perfusion
6.3 Static Cold Storage (SCS) Technique
6.4 Hypothermic Machine Perfusion

7 Global Organ Preservation Market, By Solution
7.1 Introduction
7.2 Perfadex
7.3 Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution
7.4 University of Wisconsin Solution (UW Solution)
7.5 Human bioSystem (HBS) Solution
7.6 Hypothermosol
7.7 siRNA Transplant Solution
7.8 Viaspan
7.9 Renograf
7.10 Lifor
7.1 Other Preservation Solutions

8 Global Organ Preservation Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Teva Pharmaceutical Industries Ltd.
10.2 Dr. Franz Kohler Chemie GmbH
10.3 Xvivo Perfusion AB
10.4 Claris Lifesciences Limited
10.5 Paragonix Technologies, Inc.
10.6 Transmedics, Inc.
10.7 21st Century Medicine Inc.
10.8 Bridge to Life Limited
10.9 Essential Pharmaceuticals, LLC
10.10 Waters Medical Systems LLC [Institut Georges Lopez (IGL] 10.11 Preservation Solutions, Inc.
10.12 Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.)
10.13 Organox Limited
10.14 Bristol-Myers Squibb
10.15 ToleroTech, Inc.

List of Tables
Table 1 Global Organ Preservation Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Organ Preservation Market Outlook, By Organ Type (2013-2022) ($MN)
Table 3 Global Organ Preservation Market Outlook, By Heart (2013-2022) ($MN)
Table 4 Global Organ Preservation Market Outlook, By Kidneys (2013-2022) ($MN)
Table 5 Global Organ Preservation Market Outlook, By Lung (2013-2022) ($MN)
Table 6 Global Organ Preservation Market Outlook, By Liver (2013-2022) ($MN)
Table 7 Global Organ Preservation Market Outlook, By Other Organs (2013-2022) ($MN)
Table 8 Global Organ Preservation Market Outlook, By Pancreas (2013-2022) ($MN)
Table 9 Global Organ Preservation Market Outlook, By Intestine (2013-2022) ($MN)
Table 10 Global Organ Preservation Market Outlook, By Technique (2013-2022) ($MN)
Table 11 Global Organ Preservation Market Outlook, By Normothermic Machine Perfusion (2013-2022) ($MN)
Table 12 Global Organ Preservation Market Outlook, By Static Cold Storage (SCS) Technique (2013-2022) ($MN)
Table 13 Global Organ Preservation Market Outlook, By Hypothermic Machine Perfusion (2013-2022) ($MN)
Table 14 Global Organ Preservation Market Outlook, By Solution (2013-2022) ($MN)
Table 15 Global Organ Preservation Market Outlook, By Perfadex (2013-2022) ($MN)
Table 16 Global Organ Preservation Market Outlook, By Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution (2013-2022) ($MN)
Table 17 Global Organ Preservation Market Outlook, By University of Wisconsin Solution (UW Solution) (2013-2022) ($MN)
Table 18 Global Organ Preservation Market Outlook, By Human bioSystem (HBS) Solution (2013-2022) ($MN)
Table 19 Global Organ Preservation Market Outlook, By Hypothermosol (2013-2022) ($MN)
Table 20 Global Organ Preservation Market Outlook, By siRNA Transplant Solution (2013-2022) ($MN)
Table 21 Global Organ Preservation Market Outlook, By Viaspan (2013-2022) ($MN)
Table 22 Global Organ Preservation Market Outlook, By Renograf (2013-2022) ($MN)
Table 23 Global Organ Preservation Market Outlook, By Lifor (2013-2022) ($MN)
Table 24 Global Organ Preservation Market Outlook, By Other Preservation Solutions (2013-2022) ($MN)
Table 25 North America Organ Preservation Market Outlook, By Region (2013-2022) ($MN)
Table 26 North America Organ Preservation Market Outlook, By Organ Type (2013-2022) ($MN)
Table 27 North America Organ Preservation Market Outlook, By Heart (2013-2022) ($MN)
Table 28 North America Organ Preservation Market Outlook, By Kidneys (2013-2022) ($MN)
Table 29 North America Organ Preservation Market Outlook, By Lung (2013-2022) ($MN)
Table 30 North America Organ Preservation Market Outlook, By Liver (2013-2022) ($MN)
Table 31 North America Organ Preservation Market Outlook, By Other Organs (2013-2022) ($MN)
Table 32 North America Organ Preservation Market Outlook, By Pancreas (2013-2022) ($MN)
Table 33 North America Organ Preservation Market Outlook, By Intestine (2013-2022) ($MN)
Table 34 North America Organ Preservation Market Outlook, By Technique (2013-2022) ($MN)
Table 35 North America Organ Preservation Market Outlook, By Normothermic Machine Perfusion (2013-2022) ($MN)
Table 36 North America Organ Preservation Market Outlook, By Static Cold Storage (SCS) Technique (2013-2022) ($MN)
Table 37 North America Organ Preservation Market Outlook, By Hypothermic Machine Perfusion (2013-2022) ($MN)
Table 38 North America Organ Preservation Market Outlook, By Solution (2013-2022) ($MN)
Table 39 North America Organ Preservation Market Outlook, By Perfadex (2013-2022) ($MN)
Table 40 North America Organ Preservation Market Outlook, By Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution (2013-2022) ($MN)
Table 41 North America Organ Preservation Market Outlook, By University of Wisconsin Solution (UW Solution) (2013-2022) ($MN)
Table 42 North America Organ Preservation Market Outlook, By Human bioSystem (HBS) Solution (2013-2022) ($MN)
Table 43 North America Organ Preservation Market Outlook, By Hypothermosol (2013-2022) ($MN)
Table 44 North America Organ Preservation Market Outlook, By siRNA Transplant Solution (2013-2022) ($MN)
Table 45 North America Organ Preservation Market Outlook, By Viaspan (2013-2022) ($MN)
Table 46 North America Organ Preservation Market Outlook, By Renograf (2013-2022) ($MN)
Table 47 North America Organ Preservation Market Outlook, By Lifor (2013-2022) ($MN)
Table 48 North America Organ Preservation Market Outlook, By Other Preservation Solutions (2013-2022) ($MN)
Table 49 Europe Organ Preservation Market Outlook, By Region (2013-2022) ($MN)
Table 50 Europe Organ Preservation Market Outlook, By Organ Type (2013-2022) ($MN)
Table 51 Europe Organ Preservation Market Outlook, By Heart (2013-2022) ($MN)
Table 52 Europe Organ Preservation Market Outlook, By Kidneys (2013-2022) ($MN)
Table 53 Europe Organ Preservation Market Outlook, By Lung (2013-2022) ($MN)
Table 54 Europe Organ Preservation Market Outlook, By Liver (2013-2022) ($MN)
Table 55 Europe Organ Preservation Market Outlook, By Other Organs (2013-2022) ($MN)
Table 56 Europe Organ Preservation Market Outlook, By Pancreas (2013-2022) ($MN)
Table 57 Europe Organ Preservation Market Outlook, By Intestine (2013-2022) ($MN)
Table 58 Europe Organ Preservation Market Outlook, By Technique (2013-2022) ($MN)
Table 59 Europe Organ Preservation Market Outlook, By Normothermic Machine Perfusion (2013-2022) ($MN)
Table 60 Europe Organ Preservation Market Outlook, By Static Cold Storage (SCS) Technique (2013-2022) ($MN)
Table 61 Europe Organ Preservation Market Outlook, By Hypothermic Machine Perfusion (2013-2022) ($MN)
Table 62 Europe Organ Preservation Market Outlook, By Solution (2013-2022) ($MN)
Table 63 Europe Organ Preservation Market Outlook, By Perfadex (2013-2022) ($MN)
Table 64 Europe Organ Preservation Market Outlook, By Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution (2013-2022) ($MN)
Table 65 Europe Organ Preservation Market Outlook, By University of Wisconsin Solution (UW Solution) (2013-2022) ($MN)
Table 66 Europe Organ Preservation Market Outlook, By Human bioSystem (HBS) Solution (2013-2022) ($MN)
Table 67 Europe Organ Preservation Market Outlook, By Hypothermosol (2013-2022) ($MN)
Table 68 Europe Organ Preservation Market Outlook, By siRNA Transplant Solution (2013-2022) ($MN)
Table 69 Europe Organ Preservation Market Outlook, By Viaspan (2013-2022) ($MN)
Table 70 Europe Organ Preservation Market Outlook, By Renograf (2013-2022) ($MN)
Table 71 Europe Organ Preservation Market Outlook, By Lifor (2013-2022) ($MN)
Table 72 Europe Organ Preservation Market Outlook, By Other Preservation Solutions (2013-2022) ($MN)
Table 73 Asia Pacific Organ Preservation Market Outlook, By Region (2013-2022) ($MN)
Table 74 Asia Pacific Organ Preservation Market Outlook, By Organ Type (2013-2022) ($MN)
Table 75 Asia Pacific Organ Preservation Market Outlook, By Heart (2013-2022) ($MN)
Table 76 Asia Pacific Organ Preservation Market Outlook, By Kidneys (2013-2022) ($MN)
Table 77 Asia Pacific Organ Preservation Market Outlook, By Lung (2013-2022) ($MN)
Table 78 Asia Pacific Organ Preservation Market Outlook, By Liver (2013-2022) ($MN)
Table 79 Asia Pacific Organ Preservation Market Outlook, By Other Organs (2013-2022) ($MN)
Table 80 Asia Pacific Organ Preservation Market Outlook, By Pancreas (2013-2022) ($MN)
Table 81 Asia Pacific Organ Preservation Market Outlook, By Intestine (2013-2022) ($MN)
Table 82 Asia Pacific Organ Preservation Market Outlook, By Technique (2013-2022) ($MN)
Table 83 Asia Pacific Organ Preservation Market Outlook, By Normothermic Machine Perfusion (2013-2022) ($MN)
Table 84 Asia Pacific Organ Preservation Market Outlook, By Static Cold Storage (SCS) Technique (2013-2022) ($MN)
Table 85 Asia Pacific Organ Preservation Market Outlook, By Hypothermic Machine Perfusion (2013-2022) ($MN)
Table 86 Asia Pacific Organ Preservation Market Outlook, By Solution (2013-2022) ($MN)
Table 87 Asia Pacific Organ Preservation Market Outlook, By Perfadex (2013-2022) ($MN)
Table 88 Asia Pacific Organ Preservation Market Outlook, By Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution (2013-2022) ($MN)
Table 89 Asia Pacific Organ Preservation Market Outlook, By University of Wisconsin Solution (UW Solution) (2013-2022) ($MN)
Table 90 Asia Pacific Organ Preservation Market Outlook, By Human bioSystem (HBS) Solution (2013-2022) ($MN)
Table 91 Asia Pacific Organ Preservation Market Outlook, By Hypothermosol (2013-2022) ($MN)
Table 92 Asia Pacific Organ Preservation Market Outlook, By siRNA Transplant Solution (2013-2022) ($MN)
Table 93 Asia Pacific Organ Preservation Market Outlook, By Viaspan (2013-2022) ($MN)
Table 94 Asia Pacific Organ Preservation Market Outlook, By Renograf (2013-2022) ($MN)
Table 95 Asia Pacific Organ Preservation Market Outlook, By Lifor (2013-2022) ($MN)
Table 96 Asia Pacific Organ Preservation Market Outlook, By Other Preservation Solutions (2013-2022) ($MN)
Table 97 RoW Organ Preservation Market Outlook, By Region (2013-2022) ($MN)
Table 98 RoW Organ Preservation Market Outlook, By Organ Type (2013-2022) ($MN)
Table 99 RoW Organ Preservation Market Outlook, By Heart (2013-2022) ($MN)
Table 100 RoW Organ Preservation Market Outlook, By Kidneys (2013-2022) ($MN)
Table 101 RoW Organ Preservation Market Outlook, By Lung (2013-2022) ($MN)
Table 102 RoW Organ Preservation Market Outlook, By Liver (2013-2022) ($MN)
Table 103 RoW Organ Preservation Market Outlook, By Other Organs (2013-2022) ($MN)
Table 104 RoW Organ Preservation Market Outlook, By Pancreas (2013-2022) ($MN)
Table 105 RoW Organ Preservation Market Outlook, By Intestine (2013-2022) ($MN)
Table 106 RoW Organ Preservation Market Outlook, By Technique (2013-2022) ($MN)
Table 107 RoW Organ Preservation Market Outlook, By Normothermic Machine Perfusion (2013-2022) ($MN)
Table 108 RoW Organ Preservation Market Outlook, By Static Cold Storage (SCS) Technique (2013-2022) ($MN)
Table 109 RoW Organ Preservation Market Outlook, By Hypothermic Machine Perfusion (2013-2022) ($MN)
Table 110 RoW Organ Preservation Market Outlook, By Solution (2013-2022) ($MN)
Table 111 RoW Organ Preservation Market Outlook, By Perfadex (2013-2022) ($MN)
Table 112 RoW Organ Preservation Market Outlook, By Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution (2013-2022) ($MN)
Table 113 RoW Organ Preservation Market Outlook, By University of Wisconsin Solution (UW Solution) (2013-2022) ($MN)
Table 114 RoW Organ Preservation Market Outlook, By Human bioSystem (HBS) Solution (2013-2022) ($MN)
Table 115 RoW Organ Preservation Market Outlook, By Hypothermosol (2013-2022) ($MN)
Table 116 RoW Organ Preservation Market Outlook, By siRNA Transplant Solution (2013-2022) ($MN)
Table 117 RoW Organ Preservation Market Outlook, By Viaspan (2013-2022) ($MN)
Table 118 RoW Organ Preservation Market Outlook, By Renograf (2013-2022) ($MN)
Table 119 RoW Organ Preservation Market Outlook, By Lifor (2013-2022) ($MN)
Table 120 RoW Organ Preservation Market Outlook, By Other Preservation Solutions (2013-2022) ($MN)



【レポートのキーワード】

臓器保存、正常体温機械灌流、静的冷温保存(SCS)技術、低体温機械灌流

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 臓器保存の世界市場見通し:正常体温機械灌流、静的冷温保存(SCS)技術、低体温機械灌流(Organ Preservation - Global Market Outlook (2016-2022))]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆